Hepion Pharmaceuticals Inc Working Capital to Net Assets Ratio
Hepion Pharmaceuticals Inc working capital to net assets ratio. Hepion Pharmaceuticals Inc (HEPA) has a Working Capital to Net Assets ratio of 103.9% as of December 2025. Working capital of $2.77 Million (current assets of $3.07 Million minus current liabilities of $299.38K) is measured against net assets of $2.67 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Hepion Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hepion Pharmaceuticals Inc (2012–2025)
Working capital to net assets ratio of Hepion Pharmaceuticals Inc from 2012 to 2025. This chart shows how Hepion Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 103.9%, reflecting working capital of $2.77 Million against net assets of $2.67 Million USD. See Hepion Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Hepion Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Hepion Pharmaceuticals Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Hepion Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Hepion Pharmaceuticals Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 103.9% | $2.77 Million | $2.67 Million | $3.07 Million | $299.38K | ▲ +21.7 pp |
| 2024 | 82.1% | $-1.53 Million | $-1.86 Million | $1.61 Million | $3.14 Million | ▼ -85.4 pp |
| 2023 | 167.5% | $12.20 Million | $7.28 Million | $17.49 Million | $5.29 Million | ▲ +70.0 pp |
| 2022 | 97.5% | $48.61 Million | $49.86 Million | $56.50 Million | $7.89 Million | ▲ +1.5 pp |
| 2021 | 96.0% | $89.25 Million | $93.00 Million | $97.45 Million | $8.21 Million | ▲ +2.3 pp |
| 2020 | 93.7% | $37.97 Million | $40.52 Million | $42.63 Million | $4.66 Million | ▲ +11.9 pp |
| 2019 | 81.8% | $12.78 Million | $15.62 Million | $14.39 Million | $1.61 Million | ▲ +75.8 pp |
| 2018 | 6.0% | $118.17K | $1.98 Million | $2.97 Million | $2.85 Million | ▼ -87.4 pp |
| 2017 | 93.4% | $3.46 Million | $3.70 Million | $6.06 Million | $2.60 Million | ▼ -120.0 pp |
| 2016 | 213.4% | $2.81 Million | $1.32 Million | $7.89 Million | $5.08 Million | ▲ +117.2 pp |
| 2015 | 96.1% | $3.31 Million | $3.44 Million | $5.24 Million | $1.94 Million | ▲ +148.1 pp |
| 2014 | -51.9% | $1.52 Million | $-2.93 Million | $1.98 Million | $458.74K | ▲ +0.0 pp |
| 2013 | -51.9% | $1.52 Million | $-2.93 Million | $1.98 Million | $458.74K | ▼ -151.9 pp |
| 2012 | 100.0% | $-140.50K | $-140.50K | $86.72K | $227.21K | — |